Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload - Wikidata - awgldk - TriplyDB

Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload

Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload

http://www.wikidata.org/entity/Q28250153

about

Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction Repair Injured Heart by Regulating Cardiac Regenerative Signals Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury Therapeutic impact of follistatin-like 1 on myocardial ischemic injury in preclinical models Follistatin-like 1 in vertebrate development Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome Muscle as a secretory organ.Epicardial FSTL1 reconstitution regenerates the adult mammalian heart.Impaired elastin deposition in Fstl1-/- lung allograft under the renal capsule.Blocking follistatin-like 1 attenuates bleomycin-induced pulmonary fibrosis in mice.The involvement of follistatin-like protein 1 in osteoarthritis by elevating NF-κB-mediated inflammatory cytokines and enhancing fibroblast like synoviocyte proliferation.Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems Association of Circulating Follistatin-Like 1 Levels with Inflammatory and Oxidative Stress Markers in Healthy Men The expression and post-transcriptional regulation of FSTL1 transcripts in placental trophoblasts.Adipo-myokines: two sides of the same coin--mediators of inflammation and mediators of exercise Follistatin-like protein 1 is a critical mediator of experimental Lyme arthritis and the humoral response to Borrelia burgdorferi infection.Follistatin like 1 Regulates Hypertrophy in Heart Failure with Preserved Ejection Fraction Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture.FSTL1 as a Potential Mediator of Exercise-Induced Cardioprotection in Post-Myocardial Infarction Rats.Follistatin-like 1 protects against hypoxia-induced pulmonary hypertension in mice.Myokines in insulin resistance and type 2 diabetes.Follistatin-like protein 1 and its role in inflammation and inflammatory diseases.Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock.The AMPK Activator Aicar Ameliorates Age-Dependent Myocardial Injury in Murine Hemorrhagic Shock.Natural genetic variation of the cardiac transcriptome in non-diseased donors and patients with dilated cardiomyopathy.The Correlation between FSTL1 Expression and Airway Remodeling in Asthmatics.Cardiac myocyte-derived follistatin-like 1 prevents renal injury in a subtotal nephrectomy model.Obesity-induced kidney injury is attenuated by amelioration of aberrant PHD2 activation in proximal tubules Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells.Effect of Omega-3 Polyunsaturated Fatty Acids Supplementation on Body Composition and Circulating Levels of Follistatin-Like 1 in Males With Coronary Artery Disease: A Randomized Double-Blind Clinical Trial.Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure.Cardiomyokines from the heart.Unravelling the effects of mechanical physiological conditioning on cardiac adipose tissue-derived progenitor cells in vitro and in silico.Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans.Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.Distinct changes of myocyte autophagy during myocardial hypertrophy and heart failure: association with oxidative stress.The Role of Cardiokines in Heart Diseases: Beneficial or Detrimental?Follistatin-like 1 in development and human diseases.Cardiac Remodeling: Endothelial Cells Have More to Say Than Just NO.

P2860

Q26853363-DF5593FD-C848-4F80-BA2B-FF00DADEC410 Q28066930-C5E87EC0-B24A-4356-8FA7-AAF1012D7A33 Q28238431-7184F443-490E-449A-8416-688BCB038370 Q28273799-F5F2DA03-010A-4977-A29F-3FF14EE63A18 Q28291738-56A5BA8E-99F8-448B-B273-33FDB31B2F41 Q34032238-F1AC2F9A-DD95-455E-A4EA-047262DF901A Q34360586-3C120C83-2775-4997-93D5-94735332D96A Q34494355-F3EF0F4B-BFB4-43C3-93C8-7FF881A4C721 Q35055283-2ECBF0A0-7D60-4754-83D9-F48F82AB2D5F Q35064880-2E4AEE85-21F6-4C50-8658-6B0EAC82790B Q35530208-A2ACAE47-7A4C-4400-99B8-2006059B9937 Q35925959-38B5B6F1-17AA-40CB-B537-25817E636B97 Q36008387-32294CC0-31B1-418F-97F3-07DB328F7250 Q36278850-522EEED0-A8A2-4EED-8811-BFC04625A434 Q36939096-1D2A2DE8-B074-4608-B56F-D18570913199 Q36986322-A4C9CED3-5F55-4B44-9628-DF16FC594CF3 Q37094365-9246279C-A192-4E06-AD24-6897C6A90B87 Q37141388-DFD9D40D-3562-4F6F-BCC6-CBE53653616F Q37209367-A7E8C731-6A9B-499F-9E44-97BA8BC5A8DB Q37731385-B522D6A6-41D7-4992-8B45-34EF2721509B Q38199992-E8828739-5560-4132-9F10-332ED6147A02 Q38212545-6873B798-602B-4429-BABA-D6BB2BB965AF Q38745586-488586B4-3C42-4A70-B593-2051CD1B0C35 Q39500637-9B39A481-E361-4E2C-A10C-36FAE66140CF Q40042810-584C02B0-AFE3-47BF-A484-73D1B234DCE5 Q41440735-DCF087E6-B434-45C1-B21E-ED4391458203 Q42136100-8E267458-4B91-4899-99C6-8055E122418D Q42371719-2213AB0D-033A-4483-A3E3-B3D258139A1D Q45892533-F7F31080-FB27-4411-8CC0-1E2FCE5AA3E2 Q47103905-C63B1265-6A6D-41E4-8D99-FD2BBCB449AD Q47215993-0124C00B-7977-493F-B9E4-44D5AD31F05E Q47916949-5EC81713-7130-46E1-80BB-321A0FD26EAA Q49178138-E74B8A25-A558-40EA-881A-7AAF6FC776E5 Q49484266-56720A8B-EDD6-481A-A314-BFA8B71F544F Q52730911-B2E3DD95-D2AB-4187-9777-B79152D9D47B Q53095486-32A4C222-9311-4AFB-998F-10C9A2875A46 Q53699115-597FE103-1C8D-4DEB-A4E7-ED9C61CAE2BA Q55140242-33A5E317-419F-46F2-8E73-4A0F8B61979D Q55294487-72E17132-E792-447A-A9CA-3C75B89425A9

P2860

Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload

http://www.wikidata.org/entity/Q28250153

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cardiac myocyte follistatin-li ...... hy following pressure overload

@ast

Cardiac myocyte follistatin-li ...... hy following pressure overload

@en

Cardiac myocyte follistatin-li ...... hy following pressure overload

@nl

type

label

Cardiac myocyte follistatin-li ...... hy following pressure overload

@ast

Cardiac myocyte follistatin-li ...... hy following pressure overload

@en

Cardiac myocyte follistatin-li ...... hy following pressure overload

@nl

prefLabel

Cardiac myocyte follistatin-li ...... hy following pressure overload

@ast

Cardiac myocyte follistatin-li ...... hy following pressure overload

@en

Cardiac myocyte follistatin-li ...... hy following pressure overload

@nl

P1433

Q28250153-19FDC052-9D79-4112-8AE0-ABD43616FD99

P1476

Q28250153-9B7977BB-00E1-4516-B413-8F37EDBFC90B

P2093

Q28250153-3A73A1DC-254C-47FD-8AC0-776D2F1A71E5

Q28250153-4059EAEA-6287-4AF2-8673-5283E2B50383

Q28250153-66FAAFB0-89CD-4AEA-9C8C-76C02A42233A

Q28250153-78879CD6-B613-4787-B222-08BC14FDE3B7

Q28250153-7C1623BD-9A40-41D0-AF02-36F040F005F7

Q28250153-96FF08E6-E3CE-486F-B433-740F66D77342

Q28250153-DA749B87-799C-453C-9545-B5CC2BC2A1FB

Q28250153-EAA70057-005F-46A6-AA33-023DF97A6554

P2860

Q28250153-08975FE6-558B-43CF-A73F-457C4AC10F86

Q28250153-0A585116-5C69-4C42-80DC-7FBB8AFDBBD4

Q28250153-179525A3-1CAC-4E26-9E07-D0F5297CFDD4

Q28250153-1FB9E0A3-1011-48F5-B606-4D1DFCD31797

Q28250153-2785DDA6-6B32-4E02-921C-6919C8491A31

Q28250153-2B5466FA-B68E-4B1B-8CF6-4E848FFCC8D8

Q28250153-31B8B163-6BA8-4C69-A405-F445C59CEDB6

Q28250153-37CB82B0-3C6B-43E5-B4AB-82ACE624BC2C

Q28250153-3B28380A-47F1-4292-B80D-DD7B1F546404

Q28250153-3B9DC24D-8473-46BB-8578-E7F0D8687EC2

P304

Q28250153-F6E4C3F7-76BB-4A84-9417-95BC732181CD

P31

Q28250153-278F48DB-0DEA-4F9A-8BAD-3CB7782D58E6

P3181

Q28250153-0937E891-EF9F-49FC-A2AE-9B8F7AE37C0B

P356

Q28250153-7C70E5BC-2A66-41EF-B310-1EBA2A28AEFE

P407

Q28250153-305D368A-5FA4-4508-8648-B57DDA648730

P433

Q28250153-EAE5361C-723B-4933-9F3F-8E04E4A55D33

P478

Q28250153-45377C89-B11F-4344-9B26-7EBBE0E4539E

P50

Q28250153-1E3A1BDA-D880-4663-BFC8-160DEC7EA76D

Q28250153-28C8ED0F-4C04-4758-913D-3C778E997459

Q28250153-E3A390DE-5BD4-4A58-8AB7-DA2425FDABD5

Q28250153-EE80646E-E01B-4E69-9598-4A92DCEDFDF5

P577

Q28250153-4983A8DF-995F-4D85-BB86-CBBEFA023879

P5875

Q28250153-8D923E9F-8F59-45AA-BDD2-20F9C4B49222

P698

Q28250153-3043E15D-F34E-4619-9B00-F6FB6412B8F9

P932

Q28250153-ADB12070-5C65-4764-BA19-0E7598A824F1

P3181

P356

PNAS.1108559108

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Cardiac myocyte follistatin-li ...... hy following pressure overload

@en

P2093

Akiko Higuchi

http://www.w3.org/2001/XMLSchema#string

Bram van Wijk

http://www.w3.org/2001/XMLSchema#string

Kazuto Nakamura

http://www.w3.org/2001/XMLSchema#string

Koji Ohashi

http://www.w3.org/2001/XMLSchema#string

Masayuki Shimano

http://www.w3.org/2001/XMLSchema#string

Maurice J B van den Hoff

http://www.w3.org/2001/XMLSchema#string

Noriyuki Ouchi

http://www.w3.org/2001/XMLSchema#string

Toyoaki Murohara

http://www.w3.org/2001/XMLSchema#string

P2860

Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways

The BMP antagonist follistatin-like 1 is required for skeletal and lung organogenesis

DIP2A functions as a FSTL1 receptor

DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1--analysis of their binding with TGF-β superfamily proteins

Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure

Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development

Nitric oxide synthase modulates angiogenesis in response to tissue ischemia

A secretion trap screen in yeast identifies protease inhibitor 16 as a novel antihypertrophic protein secreted from the heart

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

Adiponectin-mediated modulation of hypertrophic signals in the heart

P304

E899-906

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1355779

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.1108559108

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

David R Pimentel

Yasuhide Asaumi

P577

2011-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51708197

http://www.w3.org/2001/XMLSchema#string

P698

21987816

http://www.w3.org/2001/XMLSchema#string

P932

3203781

http://www.w3.org/2001/XMLSchema#string